Prot#RPC01-3201: INDUCTION STUDY #1- A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Cro

Project: Research project

Project Details

StatusActive
Effective start/end date9/9/199/9/22

Funding

  • ICON Clinical Research, LLC (Prot#RPC01-3201)
  • Celgene International II Sàrl (Prot#RPC01-3201)